HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

about

HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors.

P2860

Q38599565-3223D54B-6736-4ED5-90F6-4BB5018D7F8A

P2860

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

Item

http://www.wikidata.org/entity/Q40797960

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

HIV-1 Group O Genotypes and Ph ...... ility to Antiretroviral Drugs.

@en

type

Item

label

HIV-1 Group O Genotypes and Ph ...... ility to Antiretroviral Drugs.

@en

prefLabel

HIV-1 Group O Genotypes and Ph ...... ility to Antiretroviral Drugs.

@en

P1476

HIV-1 Group O Genotypes and Ph ...... bility to Antiretroviral Drugs

@en

P2093

Annette Ratcliff

http://www.w3.org/2001/XMLSchema#string

Crystal Carpenter

http://www.w3.org/2001/XMLSchema#string

Denis M Tebit

http://www.w3.org/2001/XMLSchema#string

Elodie Alessandri

http://www.w3.org/2001/XMLSchema#string

Eric J Arts

http://www.w3.org/2001/XMLSchema#string

Hamish Patel

http://www.w3.org/2001/XMLSchema#string

P2860

TreeView: an application to display phylogenetic trees on personal computers

Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs

Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses

HIV-1 Group O Origin, Evolution, Pathogenesis, and Treatment: Unraveling the Complexity of an Outlier 25 Years Later.

The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.

Non-M variants of human immunodeficiency virus type 1.

Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics

A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates.

Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide.

P304

676-688

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/AID.2015.0318

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jean-christophe Plantier

Joseph Liu

P577

2016-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26861573

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

4931737

http://www.w3.org/2001/XMLSchema#string

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

about

P2860

P2860

HIV-1 Group O Genotypes and Phenotypes: Relationship to Fitness and Susceptibility to Antiretroviral Drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932